Sie suchten nach: sustained response rate (Englisch - Maltesisch)

sustained response
rispons sostenut

no sustained response
ebda rispons sostenut

response rate
rata ta’ rispons

overall sustained response
rispons sostenut globali

the sustained response at the end of
fil- każijiet kollha, it- trattament kien għal sena b’ follow- up ta ’ sitt xhur.

sustained virological response rates in children and adolescents
rati ta ’ rispons viroloġiku sostnut fi tfal u adolexxenti kienu simili għal dawk fl- adulti.

the overall sustained response rate after a 24-week treatment duration was 50 %.
ir-rata globali ta’ rispons sostnut wara 24 ġimgħa ta’ kura kienet 50 %.

sustained response was assessed by the response rate six months after the cessation of treatment.
rispons sostnut kien stmat mir-rata ta’ rispons sitt xhur wara l-waqfien tal- kura.

in this subgroup, there was a 92 % (89/97) sustained virological response rate.
f’dan is-sottogrupp, kien hemm rata ta’ rispons viroloġiku sostnut ta’ 92 % (89/97).

in all three treatment groups, sustained virologic response rates were similar.
fil-gruppi ta’ kura kollha t-tlieta lu huma, rati ta’ rispons viroloġiku sostnut kienu simili.

in adult patients receiving interferon in combination with ribavirin, the achieved sustained response rate is 47 %.
f’pazjenti adulti li jkunu qed jirċievu interferon ma’ ribavirin, ir-rata ta’ rispons sostnut li nkisbet hija 47 %.

sustained response rates with pegintron + ribavirin (by ribavirin dose, genotype and viral load)
i/ r rati ta ’ risponsi sostnuti b 'pegintron + ribavirin (bid- doża ta ’ ribavirin, ġenotip u viral load)

sustained response rates with viraferon peg + ribavirin (by ribavirin dose, genotype and viral load)
i/ r rati ta ’ risponsi sostnuti b 'viraferonpeg + ribavirin (bid- doża ta ’ ribavirin, ġenotip u viral load)

table 9 sustained response rates with pegintron + ribavirin (by ribavirin dose, genotype and viral load)
tabella 9 rati ta’ rispons sostnut b’pegintron + ribavirin (skont id-doża ta’ ribavirin, il- ġenotip u l-ammont virali)

the high sustained response rate in this subgroup of patients was identified in an interim analysis (n=49) and prospectively confirmed (n=48).
ir-rata għolja li nkisbet f’dan is-sottogrupp ta’ pazjenti ġiet identifikata f’analiżi li saret waqt li kien għaddej l-istudju (n=49) u kkonfermata b’mod prospettiv (n=48).

(sustained response rate of 61% achieved in a study performed in naïve patients with a ribavirin dose > 10.6 mg/ kg, p < 0.01).
ad p < 0. 01).

for patients with prior failure on therapy with nonpegylated interferon or pegylated interferon and negative at week 12, the sustained response rates were 59 % and 50 %, respectively.
għall-pazjenti li ma kinux irnexxew b’terapija li ngħatat qabel b’interferon mhux pegilat jew interferon pegilat u negattivi f’ġimgħa 12, ir-rati ta’ rispons sostnut kienu ta’ 59 % u 50 %, rispettivament.

table 6 sustained response rates with ribavirin + peginterferon alfa-2b (by ribavirin dose [mg/kg], genotype and viral load)
tabella 6: rati ta’ rispons sostnut b’ribavarin + peginterferon alfa-2b (skont id-doża ta’ ribavarin [mg/kg], ġenotip u viral load)

for patients with prior failure on therapy with non-pegylated interferon or pegylated interferon and negative at week 12, the sustained response rates were 59 % and 50 %, respectively.
għall-pazjenti li kienu fallew għat-terapija li kienet ingħatat qabel b’interferon mhux pegilat jew interferon pegilat u negattivi ma’ ġimgħa 12, it-rati ta’ rispons sostnut kienu 59 % u 50 %, rispettivament.